Conditions: Healthy Volunteers
Allocation: RANDOMIZED | Intervention model: CROSSOVER
Enrollment: 24
Healthy volunteers: yes

Brief summary:
This study involves 2 single injections of LY2963016 and 2 single injections of Lantus. There will be at least 6 days between each injection.

The study will compare LY2963016 to Lantus at two different doses.

This study is approximately 10 weeks long, not including screening. Screening is required within 4 weeks of the start of the study.

Detailed description:

Arms:
arm 1: Single 0.3 units/kilogram (U/kg) subcutaneous dose of LY2963016 arm 2: Single 0.3 U/kg subcutaneous dose of Lantus arm 3: Single 0.6 U/kg subcutaneous dose of LY2963016 arm 4: Single 0.6 U/kg subcutaneous dose of Lantus

Interventions: intervention 1: LY2963016 intervention 2: Lantus
Intervention descriptions: intervention 1: Administered subcutaneously intervention 2: Administered subcutaneously

Protocol document: